The Supervisory Board of MEDICLIN Aktiengesellschaft (MediClin) has appointed Volker Feldkamp to the Management Board of the company effective January 1, 2014. He will be the successor of Frank Abele (CEO), who will leave MediClin at the end of the year 2013 at his own request. Volker Feldkamp, before member of the Management Board of RhnKlinikum AG, will head the company as CEO after the resignation of Frank Abele.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.91 EUR | +2.46% | -1.38% | +4.38% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.38% | 147M | |
-17.57% | 16.76B | |
+3.60% | 12.65B | |
+4.64% | 11.86B | |
+4.28% | 10.28B | |
+28.40% | 8.67B | |
-6.94% | 7.6B | |
+6.44% | 6.8B | |
+8.59% | 6.52B | |
+46.39% | 4.53B |
- Stock Market
- Equities
- MED Stock
- News MEDICLIN AG
- MEDICLIN Aktiengesellschaft Announces CEO Changes, Effective January 1, 2014